Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Discernment into Innovative Research and Care Practice Approaches Towards Dementia
- Dementiacare 2017

Welcome Message

Meet Inspiring Speakers and Experts throughout the world to disseminate and share their Research proposals at inclusive 100+ Allied Academics Conferences, Workshops and Symposiums every year on Medical, Science and Technology.

Allied Academies invites all the participants from all over the world to attend 7th International Conference on Dementia & Care Practice slated in August 14-16, 2017 at Toronto, Ontario, Canada.

Dementia Care 2017 is amongst the most imperative gatherings on Dementia & Care Practice, a chance to unite each one of those with an enthusiasm; including clinicians, mind experts, specialists, researchers, individuals with dementia, relatives close by staff and volunteers of Alzheimer or Dementia affiliations.

Dementia, amongst the biggest cosmic public health challenges, is a syndrome – usually of a chronic or progressive nature – in which there is deterioration in cognitive function and mainly affects memory, thinking, orientation, comprehension, calculation, learning capacity, language, and judgement and reasoning problems but not consciousness.

Dementia Care 2017 mainly focus on Alzheimer’s disease, Dementia, Neurological changes in brain, Dementia Imaging techniques, Disease Mechanisms, Geriatrics and Neurodegenerative Disorder, Pathophysiology, Neuropharmacology and therapeutic approaches, Care practice and Awareness, Current Research in Dementia and Alzheimer’s Disease.

This one of a kind, multi-disciplinary occasion is a most loved among pioneers in the field and is an immaculate chance to share and gain from each other.

 


Market Analysis

Dementia is a common term for loss of memory and other mental abilities severe enough to interfere with daily life. It is caused by concrete changes in the brain, mainly associated with neurons.

Dementia, including Alzheimer’s disease, is amongst the immense global public health challenges siding our generation.

The recent surveys show that nearly 46.8 million people in world are living with dementia and the number will escalate double every 20 years, reaching 74.7 million in 2030 and 131.5 million in 2050.

As per National Institute of Health, the second biggest type of dementia is multi infarct dementia, which represents the most extreme instances of individuals who are over the age of 65. Accordingly, expanding geriatric populace base worldwide is likewise impelling the worldwide multi infarct dementia showcase. Different innovative headways in a few inhibitors utilized for the counteractive action of dementia is another eminent component anticipated that would additionally fuel the worldwide multi infarct dementia advertise over the estimate time frame. 

Geologically, the general dementia market is portioned into North America, Asia Pacific, Europe, and Latin America. Starting 2014, North America held biggest piece of the pie as far as income attributable to the expanding occurrences of multi infarct dementia combined with expanding geriatric populace base. European market showed comparative traits and took after North American dementia showcase. 

Asia Pacific is relied upon to develop at a high pace because of expanding mindfulness about avoidance of cerebrum strokes in this area. Japan attributable to expanded geriatric base speaks to roughly more than half of the dementia cases in Asia Pacific. The created countries, for example, Japan, Canada, France, Germany and U.S. are expected to witness great development over the gauge time frame.

In a year's chance, Alzheimer's influences a greater number of individuals than tumour, coronary illness and AIDS consolidated. As the info graphic appears, just coronary illness, the nation's main source of death, tops it regarding yearly care costs. (Coronary illness expenses are $264 billion; Alzheimer's are $203 billion.) 

Alzheimer's falls not just among the main 10 reasons for death in the nation, yet it's the fifth driving reason for death for individuals matured 65 and over. Truth be told, one in each three seniors bites the dust with Alzheimer's or another type of dementia

Moreover, it was estimated that nearly 564,000 Canadians are living with dementia & the combined health-care system and out-of-pocket caregiver costs total an estimated $10.4 billion per year.

Throughout the following decade, instances of Alzheimer's are anticipated to increment by 40 percent, excepting a therapeutic achievement. However the U.S. government spends short of what one percent of its financial plan on Alzheimer's exploration. 

On the off chance that exploration dollars stay inaccessible, Alzheimer's & Dementia will influence about 14 million seniors by the year 2050, almost triple the quantity of individuals it influences today.

The global healthcare costs of dementia have spike from US$ 604 billion in 2010 to US$ 818 billion in 2016 with an increase of 35.4%.

2016 Report by Alzheimer's Disease International checked on that Having characterized diagram social insurance pathways for individuals living with dementia for moderately all around resourced high wage nations, and less all around resourced center wage nation settings, it is evaluated that the expanding expenses of care from 2015 to 2030, bookkeeping for anticipated increments in the quantities of individuals living with dementia, and an anticipated increment in analytic scope from half to 75% in High waged nations and from 10% to half in medium waged nations.

Our goal is to provide an outstanding global event which screens the thorough spectrum of research in dementia and share the cross-cultural experiences of various procedures related to it.

Conference Highlights

Shape the fate of the field by sharing your work at Dementia Care 2017.

The Scientific Organising Committee is currently accepting entries for publication presentations, oral sessions and included research sessions on the following tracks:

o    Dementia: Alzheimer’s and Vascular Dementia

o    Neurodegenerative Diseases

o    Dementia Care Research

o    Dementia Care Practice

o    Neurological Nursing

o    Person living with Dementia

o    Aging and Dementia

o    Factors influence Dementia

o    Diagnosis and Prognosis of Dementia

o    Animal Models and Translational Medicine

o    Bio markers in Dementia

o    Amyloid Protein in Dementia

o    Neuropathology

o    Neuropharmacology

o    Therapeutic Approaches towards Dementia

 

About

Allied Academies Publication is an amalgamation of several esteemed academic and scientific associations known for promoting scientific temperament. Established in the year 1997, Andrew John Publishing Group is a specialized Medical publisher that operates in collaboration with the association and societies.  This publishing house has been built on the base of esteemed academic and research institutions including The College of Audiologists and Speech Language Pathologists of Ontario(CASLPO), The Association for Public Safety Communications Officials of Canada (APCO), The Canadian Vascular Access Association (CVAA), The Canadian Society of Internal Medicine (CSIM), The Canadian Hard of Hearing Association (CHHA), Sonography Canada, Canadian Association of Pathologists (CAP-ACP) and The Canadian Association of Neurophysiologic Monitoring (CANM).

Dementia, including Alzheimer’s disease, is one of the biggest global public health challenges facing our generation.

The recent surveys show that nearly 46.8 million people in world are living with dementia and the number will escalate double every 20 years, reaching 74.7 million in 2030 and 131.5 million in 2050. Even the global healthcare costs of dementia have spike from US$ 604 billion in 2010 to US$ 818 billion in 2015 with an increase of 35.4%.Much of the increase will be in developing countries like Western Europe and North America.

Already 62% of people with dementia live in developing countries. Today, over 35 million people worldwide currently live with the condition. This number is expected to double by 2030 and more than triple by 2050 to 115 million.

No treatments available to slow down or stop the brain damage caused by Alzheimer’s disease, although several medications can transiently improve the symptoms of dementia among people. In two decades, it is estimated that 1.4 million Canadians will suffer from dementia, yielding the economy almost $300 billion per year. Globally, dementia cost $600 billion a year.

Alzheimer's falls not just among the main 10 reasons for death in the nation, yet it's the fifth driving reason for death for individuals matured 65 and over. Truth be told, one in each three seniors bites the dust with Alzheimer's or another type of dementia.

Organizing Committee
OCM Member
Claire M. Henry
Director
Lourdes Memory Center
Boston, USA
OCM Member
Jerzy Leszek
vice-director of the Psychiatry Department and head of Alzheimer’s disease Laboratory, Psychiatry
Wroclaw Medical University
Warsaw, Poland
OCM Member
Joanna Richardson- Jones
CEO
Alzheimer Family Service Centre
Phoenix, USA
OCM Member
Dr. Lin Zhang
Medical Director
Deep Brain Stimulation Program UC Davis Health System
Davis, USA
OCM Member
Azza A Ali
Head of Department, Pharmacology and Toxicology
Al azhar University
cairo, Egypt
OCM Member
Helga Rohra
Member
Alzheimer Europe
Berlin, Germany
OCM Member
Joanna LaFleur
CEO
Dementia Specialists Homecare and Memory Lane Assisted Living
San Francisco, USA
OCM Member
Donald A. Davidoff
Director and Head of Department, Neuropsychology
Harvard Medical School
Boston, USA
OCM Member
Dr. Kurt Jellinger
Director
Institute of Clinical Neurobiology
Vienna, Austria
OCM Member
Dr. Davide Vito Moretti
Chief of the Rehabilitation in Alzheimers Disease Operative Unit
National Institute of Research and Cure for Alzheimer's disease
Naples, Italy
OCM Member
Dr. Livio Luongo
Research Scientist
Second University of Naples
Naples, Italy
Renowned Speakers
Venue
&
Hospitality

Join The Discussion

Contact Desk

Drop us a mail program enquiry

Amanda Cross

dementiacare@alliedconferences.org

+1 800-858-2189

Sponser/Exhibiting/advertising

Amanda Cross

dementiacare@alliedconferences.org

+1 800-858-2189

General queries

Amanda Cross

dementiacare@alliedconference.com

+1 800-858-2189

Special Issues
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by

Mail us at

Drop us a mail program enquiry
dementiacare@alliedconferences.org
Sponser/Exhibiting/advertising
dementiacare@alliedconferences.org
General queries
dementiacare@alliedconference.com
More details about sponsorship:sponsors@alliedacademies.com
Copyright © 2017-2018 Allied Academies, All Rights Reserved.